Turn on cookies to sign in
Signing in saves your progress to your Curie account. We can only do that with cookies on — turn them on to continue.

A new microscopy method developed by researchers from Bielefeld University and the University of Vienna can reveal the smallest cellular structures while simultaneously tracking changes in their molecular environment. The FLIM-SIM technique combines super-resolution imaging with fluorescence lifetime measurements, offering unprecedented detail on how drugs interact with living cells. It could be a game-changer for cancer drug research and beyond.
Researchers from Bielefeld University and the University of Vienna have developed a powerful new microscopy technique that could transform how scientists study drug effects at the cellular level. The method — called FLIM-SIM — merges two existing technologies: Structured Illumination Microscopy (SIM), which visualizes structures too small for conventional light microscopes, and Fluorescence Lifetime Imaging Microscopy (FLIM), which tracks how long fluorescent molecules emit light — a signal that shifts depending on the cell's molecular environment, such as changes in pH.
The technique was demonstrated on a human bone cancer cell line and is already being applied within the European CHEM-SCAN project, which is exploring how chemotherapy agents can be fine-tuned to target both tumors and their metastases more effectively.
By the Numbers:
Why it matters: Understanding exactly how drugs behave inside individual cells — and what side effects they trigger at the molecular level — is critical for developing safer, more effective treatments. This technique gives researchers a much sharper lens for that work, with direct implications for cancer therapy development and broader biomedical research.